GRANT SEAN (Chief Financial Officer) purchased 504.0% of their position (5K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $83.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/23/2023ACC: 0001209191-23-039323
Officer· Chief Financial Officer
Since Jul 2021
+5K
Net shares
Net buyer
$83.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Class A Common Stock
Indirect
Shares
+5K
Price / share
$16.60
Trade value
$83K
% of position
504.0%
6/23/2023
992.00→5.99K
Total
Net shares
+5K
Net value
$83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 6/23/2023 | P · Purchase | +5K | $16.60 | $83K | 504.0% | 992.00 | 5.99K |
| Total | +5K | $83K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Class A Common Stock
DirectShares owned49.93K
Class A Common Stock
IndirectShares owned857.00
Class A Common Stock
IndirectShares owned335.00
Class A Common Stock
IndirectShares owned2.82K
Total
49.93K direct·4.01K indirect53.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 49.93K | Direct |
| Class A Common Stock | 857.00 | Indirect |
| Class A Common Stock | 335.00 | Indirect |
| Class A Common Stock | 2.82K | Indirect |
| Total | 53.94K | 49.93K direct·4.01K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported